Qilian International Holding Group Limited Total Liabilities

Latest as of March 2026: $36.57 Million USD

Qilian International Holding Group Limited total liabilities. Based on the latest financial reports, Qilian International Holding Group Limited (BGM) has total liabilities worth $36.57 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Qilian International Holding Group Limit to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Qilian International Holding Group Limited (2017–2025)

Total liabilities of Qilian International Holding Group Limited from 2017 to 2025. This chart illustrates how Qilian International Holding Group Limited's total liabilities have evolved over time, based on quarterly financial data. Explore Qilian International Holding Group Limit (BGM) long-term investment share to see how much of total assets are deployed in long-term investments.

Qilian International Holding Group Limited Competitors by Total Liabilities

The table below lists competitors of Qilian International Holding Group Limited ranked by their total liabilities.

Company Country Total Liabilities
TuHURA Biosciences Inc
NASDAQ:HURA
USA $13.25 Million
Nien Hsing Textile Co Ltd
TW:1451
Taiwan NT$1.48 Billion
Daishin Securities Co Ltd Pref 2
KO:003547
Korea ₩38.04 Trillion
John Hancock Investors Closed Fund
NYSE:JHI
USA $91.36 Million
Europen Endustri Insaat Sanayi ve Ticaret A.S.
IS:EUREN
Turkey TL4.12 Billion
HMCIB SPAC 3
KQ:226340
Korea ₩29.73 Billion
An Phat Plastic and Green Environment JSC
VN:AAA
Vietnam ₫6.77 Trillion
The Century Co., Ltd.
KO:002420
Korea ₩25.21 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Qilian International Holding Group Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Qilian International Holding Group Limit (BGM) total assets.

Liquidity & Leverage Metrics

Qilian International Holding Group Limited Total Liabilities Ratios Explained

Qilian International Holding Group Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.25 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.09 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.08 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Qilian International Holding Group Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Qilian International Holding Group Limited (2017–2025)

The table below shows the annual total liabilities of Qilian International Holding Group Limited from 2017 to 2025.

Year Total Liabilities Change
2025-09-30 $41.68 Million +367.73%
2024-09-30 $8.91 Million +29.01%
2023-09-30 $6.91 Million -27.78%
2022-09-30 $9.56 Million -48.82%
2021-09-30 $18.68 Million -3.20%
2020-09-30 $19.30 Million +52.82%
2019-09-30 $12.63 Million -19.13%
2018-09-30 $15.62 Million -20.82%
2017-09-30 $19.73 Million --

About Qilian International Holding Group Limited

NASDAQ:BGM USA Drug Manufacturers - Specialty & Generic
Market Cap
$3.63 Billion
Market Cap Rank
#18796 Global
#4368 in USA
Share Price
$9.54
Change (1 day)
+0.00%
52-Week Range
$0.24 - $10.75
All Time High
$58.32
About

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and… Read more